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Malnutrition affects hundreds of millions of people in the world and is a major cause of 
mortality1,2. In many cases malnutrition is associated with diarrhea and intestinal 
inflammation further contributing to morbidity and death2. The mechanisms by which 
unbalanced dietary nutrients affect intestinal homeostasis are largely unknown. Here we 
report that deficiency in murine Angiotensin-converting enzyme 2 (Ace2), encoding a 
key regulatory enzyme of the renin-angiotensin system (RAS) involved in acute lung 
failure3, cardiovascular functions4, and SARS infections5, results in highly increased 
susceptibility to intestinal inflammation induced by epithelial damage. Mechanistically, 
ACE2 exhibits a RAS-independent function regulating intestinal amino acid 
homeostasis, expression of antimicrobial peptides, and the ecology of the gut 
microbiome. Transplantation of the altered microbiota from Ace2 mutant mice into 
germfree wild type hosts was able to transmit the increased propensity to develop severe 
colitis. ACE2-dependent changes in epithelial immunity and the gut microbiota can be 
directly regulated by the dietary amino acid tryptophan. Our results identify ACE2 as a 
key regulator of dietary amino acid homeostasis, innate immunity, gut microbial 
ecology, and transmissible susceptibility to colitis. These results provide a molecular 
explanation how amino acid malnutrition can cause intestinal inflammation and 
diarrhea.  
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The renin-angiotensin system (RAS) has now been studied for more than a century. The 
RAS is regulated by the opposing actions of two key carboxypeptidases, angiotensin 
converting enzyme (ACE) and ACE2 ref.4,6,7. In addition to its catalytic activity, we and 
others have recently found that ACE2 associates with the neutral amino acid transporter 
B0AT1 and that ACE2 is required for expression of this transporter on the luminal 
surface of intestinal epithelial cells8,9. Variants in the B0AT1 (SLC6A19) gene have been 
identified as a cause of Hartnup’s disease10, a rare autosomal recessive disorder 
associated with pellagra-like symptoms including diarrhea that manifests under 
conditions of malnutrition11. However, the in vivo function of ACE2 in the gut 
epithelium remained to be investigated.  
 
Morphological and ultra-structural analysis of the small and large intestine of Ace2 
knock-out mice did not reveal any alterations. Intriguingly, when we challenged Ace2 
deficient mice with dextran sodium sulfate (DSS), an irritant that disrupts the intestinal 
epithelial barrier and results in colitis12, a profoundly increased inflammatory reaction 
was observable compared to wild type littermates. We detected an enhanced infiltration 
of inflammatory cells, significant shortening of the colon length, increased intestinal 
bleeding (hemoccult), crypt damage, inflammation (redundant?), weight loss, and 
severe diarrhea resulting in an overall increased disease activity13 (Fig. 1a-c, 
Supplementary Fig. 1). Similar results were obtained using Trinitrobenzene sulphonic 
acid (TNBS) -induced colitis (Supplementary Fig. 2). Thus, genetic inactivation of the 
key RAS enzyme ACE2 results in severe colitis following intestinal injury.  
 
To test whether the severe colitis phenotype is due to the catalytic activity of ACE2, we 
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treated mice with recombinant soluble ACE2 (rsACE2). We and others have shown that 
rsACE2 rescues virtually all previously reported in vivo ACE2 functions within the 
RAS system3,14. As it lacks the transmembrane domain, soluble ACE2 cannot associate 
with the neutral amino acid transporter B0AT1 and thus cannot stabilize its cell-surface 
localization8. Treatment of mice with rsACE2 did not rescue the severe DSS-induced 
colitis phenotype of Ace2 mutant mice (Supplementary Fig. 3a-h). One in vivo 
consequence of Ace2 deletion within the RAS is accumulation of angiotensin II (AngII), 
which then primarily acts on the G-protein coupled AT1a receptor (Agtr1a)ref.3. We 
indeed observed increased AngII levels in the colon of DSS-treated Ace2 mutant mice 
that were reduced to background levels after treatment with rsACE2 (Supplementary 
Fig. 3i). To rule out that locally increased AngII might cause severe colitis, we 
generated Agtr1a-/-Ace2-/y mice. Deletion of Agtr1 did not rescue the severe 
DSS-induced colitis (Supplementary Fig. 4), indicating that these effects are 
independent of the classical RAS system. Whether ACE inhibition might alter the 
phenotype of Agtr1a-/-Ace2-/y mice needs to be further examined. In addition to cleaving 
AngII, ACE2 exhibits catalytic activity towards a second peptide system, Apelin15. 
However, DSS-induced colitis was not altered in mice carrying genetic mutations in 
Apelin (Supplementary Fig. 5) or its receptor Apj (Supplementary Fig. 6). Thus, the 
catalytic activity of ACE2, essential for its function in the RAS and Apelin cleavage, has 
no overt role in DSS-induced intestinal inflammation.  
 
It had been reported that the RAS can control immune functions16. However, in 
unchallenged Ace2 mutant mice, we did not observe any apparent differences in 
immune cell populations of the colon and small intestine (insert: “not shown”?). 
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TLR1-9 mRNA levels in jejunum, ileum, and colon were largely similar in Ace2 
deficient and wild type mice, with the exception of TLR5 and TLR9 in the colon 
(Supplementary Fig. 7).  Transplantation of bone marrow from Ace2 mutant mice 
(KO) into wild type (WT) mice (KO  WT) did not result in any obvious effect on 
DSS-induced colitis as compared to WT  WT transplant recipients. By contrast, 
reconstitution of Ace2 mutant mice with WT bone-marrow (WT  KO) led to an 
increased severity of DSS-induced colitis that was indistinguishable from the KO  
KO control group (Supplementary Fig. 8). Thus, ACE2 exerts its role on intestinal 
inflammation in non-haematopoietic cells.  
 
ACE2 expression was primarily mapped to the luminal surface of differentiated small 
intestinal epithelial cells, whereas lower ACE2 expression is observed in crypt cells and 
the colon (Supplementary Fig. 9a,b & 10a). Ace2 inactivation had no overt effect on 
basal proliferation of small intestinal or colon crypt cells (Supplementary Fig. 10a,b) 
nor did it affect apoptosis rates of intestinal epithelial cells (Supplementary Fig. 10a,c). 
ACE levels were slightly, albeit not significantly, increased in the jejunum of Ace2-/y 
mice (Supplementary Fig. 9c,d). As reported previously8, protein expression of the 
neutral amino acid transporter B0AT1 was absent in the small intestine of Ace2 mutant 
mice, whereas mRNA expression was not affected (Supplementary Figs. 9e,f & 11a). Due 
to the lack of intestinal B0AT1 protein expression, serum levels of the neutral amino 
acids valine (Val), threonine (Thr), and tyrosine (Tyr), and the essential amino acid 
tryptophan (Trp) were markedly reduced in Ace2-/y mice (Supplementary Fig. 11b). The 
marked reduction in tryptophan correlates with human data, as patients suffering from 
Hartnup´s disease caused by B0AT1 mutations or malnutrition such as in anorexia 
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nervosa exhibit reduced tryptophan serum levels17,18.  
 
ACE2 is a chimeric protein that emerged from the duplication and fusion of two genes: 
homology with ACE at the catalytic domain and with Collectrin (Tmem27) in the 
membrane proximal domain19. Inactivation of Collectrin in mice results in a near 
complete downregulation of apical amino acid transporters such as B0AT1 in the kidney 
thereby regulating renal amino acid re-absorption19. By contrast, ACE2 associates with 
B0AT1 on the luminal surface of intestinal epithelial cells, i.e. ACE2/B0AT1 regulate the 
uptake of neutral amino acids in the intestine where Collectrin is not expressed 
(Supplementary Fig. 11a,c & 12). In both Collectrin and Ace2 mutant mice, tryptophan 
is reduced in the serum (Supplementary Fig. 11b and ref. 19). To test whether impaired 
re-absorption of amino acids in the kidney might also result in altered susceptibility to 
colitis, we challenged Collectrin-/- mice with DSS. However, genetic ablation of 
Collectrin did not affect DSS-induced colitis (Supplementary Fig. 13). Although genetic 
inactivation of both Ace2 or Collectrin result in a similar deregulation of amino acids in 
the serum, functionally only the loss of ACE2 affects the susceptibility to intestinal 
inflammation.  
 
We, therefore, speculated that the function of ACE2 in intestinal uptake of dietary amino 
acids might underlie the observed phenotype. To test this hypothesis, we fed Ace2 
mutant and control mice a protein free-diet (PFD) to eliminate dietary amino acids and 
challenged these mice with DSS at a dose (1%) that triggers only very mild colitis. 
Basal weight loss was comparable among control and Ace2 mutant mice during the 
period of the PFD (Supplementary Fig. 14a). Moreover, average food intake did not 
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show a significant difference between Ace2 deficient and control mice fed PFD or 
normal chow (Supplementary Fig. 14b). Importantly, PFD markedly worsened 
DSS-triggered colitis in wild type mice to levels seen in Ace2 mutants (Fig. 1d-f; 
Supplementary Fig. 14c-g). Thus, protein malnutrition alters the severity of 
DSS-induced intestinal inflammation.  
 
The general lack of dietary protein might induce broad effects on several organ systems. 
We, therefore, set out to define whether a specific amino acid might be responsible for 
the severe inflammatory phenotype. Since serum tryptophan was markedly decreased in 
Ace2 mutant mice, we focused on this essential amino acid. Tryptophan is required for 
the in vivo generation of nicotinamide (vitamin B3/niacin)17 and insufficient niacin or 
tryptophan in the diet are the cause of pellagra, a disease still endemic in many countries 
with protein malnutrition20. More than 90% of pellagra patients develop colitis11 and for 
nearly 80 years nicotinamide (NAM) has been used as treatment for pellagra. In Ace2 
mutant mice, NAM almost completely alleviated the severe colitis and diarrhea (Fig. 
2a-c; Supplementary Fig. 15). To demonstrate that the severe colitis in Ace2 deficient 
mice is due to impaired tryptophan uptake, we provided tryptophan in form of a Gly-Trp 
dipeptide to bypass the loss of the single amino acid transporter B0AT1. Dietary 
dipeptidic tryptophan (Trp+) restored serum tryptophan levels (Supplementary Fig. 16a) 
and rescued the enhanced DSS-susceptibility of Ace2-/y  mice (Fig. 2d-f; Supplementary 
Fig. 16b-d). Tryptophan free (Trp-) diet resulted in a dramatic increase in susceptibility 
to DSS-induced inflammation (Supplementary Fig. 17a-h). In addition, Trp- diet 
markedly worsened weight loss in wild type mice challenged with TNBS 
(Supplementary Fig. 17i-l). Our results show that deficiency of Ace2 causes a critical 
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impairment of local tryptophan homeostasis which alters the susceptibility to intestinal 
inflammation.  
 
It is conceivable that an altered amino acid availability in the epithelium could lead to 
decreased regenerative responses and repair mechanisms after epithelial injury21,22. 
However, proliferation rates and cell death of small intestinal and colon epithelial cells 
were comparable between control and Ace2 mutant mice following DSS challenge 
(Supplementary Fig. 18). However, expression of multiple antimicrobial peptides was 
markedly reduced in isolated gut ileal epithelial cells from unchallenged Ace2 mutant 
mice (Fig. 3a; Supplementary Fig. 19a-c). Tryptophan-free (Trp-) diet of wild type mice 
also resulted in a significant downregulation of antimicrobial peptides (Fig. 3b). Similar 
downregulation of antimicrobial peptides was observed upon feeding wild type mice a 
protein-free diet (Supplementary Fig. 20a). By contrast, dietary NAM (Supplementary 
Fig. 20b-g) and dipeptidic tryptophan (Trp+) (Fig. 3c and Supplementary Fig. 20h,i) 
triggered induction of antimicrobial peptides in intestinal epithelial cells from Ace2 
mutant and wild type mice. Thus, dietary tryptophan controls expression of small 
intestinal antimicrobial peptides.  
 
Amino acids and nicotinamide can activate mTOR, involved in cell proliferation, 
survival, protein synthesis and transcription23. In epithelial intestinal cells from 
unchallenged Ace2 mutant mice we observed markedly impaired p70S6 kinase activity 
(Supplementary Fig. 21a) as well as reduced S6 phosphorylation (Fig. 3d and 
Supplementary Fig. 21b), indicative of reduced mTOR activity. A similar reduction of 
mTOR activity was recently reported in mice lacking B0AT1ref.24. Administration of 
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dipeptidic tryptophan (Trp+) resulted in increased mTOR activity in the small intestine 
of Ace2 mutant mice (Fig. 3e). In vivo inhibition of mTOR with rapamycin (RAPA) in 
wild type mice resulted in a significant downregulation of antimicrobial peptide 
expression, an effect that could not be rescued by NAM (Supplementary Fig. 22a). 
Moreover, administration of RAPA before the first challenge with DSS increased the 
severity of colitis (Fig. 3f; Supplementary Fig. 22b-h). Of note, although acute mTOR 
inhibition may have beneficial effects in murine colitis models25, mTOR blockade has 
not been proven successful in human clinical trials in inflammatory bowel disease 
(IBD)26. We could delete this sentence if still too long? Thus, at the molecular level, 
nicotinamide and dietary tryptophan appear to exert their effects on intestinal 
antimicrobial peptides and colitis via the mTOR pathway.  
 
How does ACE2 regulated uptake of tryptophan in the small intestine affect 
DSS-induced inflammation in the colon? It has been shown that α-defensins secreted 
into the ileum lumen persist in a functional state throughout the entire gut27 and that 
alterations in antimicrobial peptides can affect the ecology of the small and large bowel 
microbiota28. We therefore performed deep profiling of the intestinal microbiome of 
Ace2 mutant and wild type littermates using 16s rDNA fingerprinting. The luminal 
ileocecal microbiome of Ace2 mutant mice was markedly altered as shown by weighted 
(Bray-Curtis) (Fig. 4a) and unweighted (Unifrac) (Fig. 4b) analyses. Distinct 
operational taxonomical units (OTUs) are overrepresented in Ace2 mutant mice (Fig. 
4c; Supplementary Tables 1 & 2). RAPA treatment resulted in a distinct alteration of the 
ileocecal gut microbiome in wild type animals which was still closer related to wild type 
than to Ace2-/y animals (Supplementary Fig. 23a-c; Supplementary Tables 3 & 4); RAPA 
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acts on many different cell types that in addition to the changes in intestinal epithelial 
cells could alter microbiota composition29. Importantly, both dipeptidic tryptophan 
(Trp+) and NAM treatment reverted the composition of the intestinal microbiota of 
Ace2 mutant mice to be more similar to wild type littermates (Fig. 4a-c, Supplementary 
Fig. 24a-c, Supplementary Tables 1, 2, 5 & 6). Thus, de-regulation of tryptophan amino 
acid homeostasis in Ace2 mutant mice alters the intestinal microbiome.  
 
Consistent with an alteration in the intestinal microbiome, antibiotic treatment of Ace2 
mutant mice alleviated the severe colitis (Supplementary Fig. 25). We finally performed 
gut microbiome transplants from control and Ace2 mutant mice into germfree hosts 
followed by DSS challenge. Transplantation of the ileocecal gut microbiota from Ace2 
mutant mice transmitted the inflammatory phenotype to wild type hosts as compared to 
mice that were colonized with the microbiota of Ace2+/y mice (Fig. 4d,e; Supplementary 
Fig. 26a-f). Expression of antimicrobial peptides in wild type mice did not change 
significantly upon transplantation of Ace2+/y or Ace2-/y microbiota within the timeframe 
of analysis (Supplementary Fig. 26g).  
 
We propose the following scenario how malnutrition and tryptophan deficiency can 
cause diarrhea and colitis. Dietary tryptophan is primarily absorbed via the 
B0AT1/ACE2 transport pathway on the luminal surface of small intestinal epithelial 
cells. This results in the activation of mTOR either directly through nutrient sensing 
and/or through the tryptophan-nicotinamide pathway. mTOR then regulates expression 
of antimicrobial peptides which affect the intestinal composition of the gut microbiota. 
Whether pathways other than mTOR and antimicrobial peptides also contribute to the 
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altered microbiome needs to be explored. Our results further indicate that under 
conditions of intestinal injury, such an altered microbiome contributes to the severity of 
colitis. Importantly, our data indicate that the essential amino acid tryptophan and its 
metabolite nicotinamide are key regulators of gut microbiota and propensity to 
inflammation.  
 
Malnutrition is a major global health burden affecting up to one billion people in the 
world and its consequences such as colitis and diarrhea are often fatal1,2. In addition, 
chronic inflammatory conditions of the intestine, cachexia, anorexia nervosa, or amino 
acid mal-absorption constitute severe clinical problems30. Our results provide novel 
mechanistic insights how protein malnutrition can lead to colitis and diarrhea. Our data 
also identify a molecular crosstalk between the RAS system and intestinal amino acid 
homeostasis via ACE2 and provide a direct link of dietary amino acid metabolism to 
innate immunity, the composition of the intestinal microbiota, and susceptibility to 
colitis.  
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METHODS SUMMARY 
Colitis models. Ace2, Collectrin, Agtr1, Apj, and Apelin mutant mice have been 
described. Mice were given protein-free and tryptophan-free diet, tryptophan 
di-peptides, NAM, rapamycin, or were treated with catalytically active murine ACE2 
protein and challenged with DSS or TNBS. Bone marrow transplantations were 
performed in lethally irradiated Ace2 mutant and wild type mice. For microbiota 
transplantation, cecal and ileum extracts from Ace2+/y or Ace2-/y mice were transplanted 
to germ free hosts. Severity of colitis was monitored as described13. All experiments 
were performed in accordance with institutional guidelines. 
Expression analyses. Small and large intestinal epithelial cells and mucosal cells were 
purified and gene expression assessed using qRT-PCR. Protein expression was 
determined by Western blot and localized using immunohistochemistry. Immune cell 
populations were determined by FACS.  
Microbiota sequencing. Genomic DNA was extracted from the terminal ileum, 
amplified by PCR, and sequenced using Roche 454 titanium chemistry. All sequence 
reads were filtered for quality and length using PANGEA. Sequences were clustered 
using average neighbour algorithm into species level operational taxonomical units 
(OTUs). Distance matrices between samples were generated based on weighted 
(Bray-Curtis similarity) and non-weighted (unweighted UniFrac) algorithms and shown 
as principal coordinate analysis (PCoA). Spearman correlations and similarity 
percentage analysis (SIMPER) were performed to determine significant differences 
among bacterial communities among genotype and diet groups.  
Full Methods and any associated references are available in the online version of the 
paper at www.nature.com/nature.  
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Figure legends 
Figure 1. Ace2 deficiency and protein malnutrition worsen DSS-induced colitis.  
a, Colon histopathology, b, Percent weight loss and c, diarrhea scores in control and 
DSS-treated Ace2+/y and Ace2-/y littermates. Note crypt damage (arrowheads), 
ulcerations (arrow), and infiltration of inflammatory cells (asterixes) in DSS-treated 
Ace2-/y mice. H&E staining on day 7 after DSS challenge. Scale bars, 100μm. d, Colon 
histopathology (H&E, day 4 after DSS challenge; scale bars, 100μm), e, percent weight 
loss, and f, diarrhea scores of DSS-treated Ace2+/y and Ace2-/y littermates fed either 
normal chow (Control) or a protein free diet (PFD; <0.2% protein). All values are mean 
± SEM of 5-9 mice per group. *P<0.05, **P<0.01 comparing DSS-treated Ace2+/y vs. 
Ace2-/y littermates or Ace2+/y mice on normal diet vs. PFD (paired-t-test).  
 
Figure 2. Rescue of severe colitis with nicotinamide or tryptophan di-peptides.  
a, Colon histopathology (H&E, day 10 after DSS challenge; scale bars, 100μm), b, 
percent weight loss, and c, diarrhea scores of DSS-treated Ace2+/y and Ace2-/y littermates 
that received vehicle or nicotinamide (NAM) in their drinking water. NAM treatment 
was started 3 days before DSS challenge. d, Colon histopathology (H&E, day 7; scale 
bars, 100μm), e, percent weight loss, and f, crypt injury scores of Ace2+/y and Ace2-/y 
mice fed a di-peptidic tryptophan diet (Trp+) or normal chow (Control). Values are 
mean ± SEM of 3-10 mice per group. *P<0.05, **P<0.01 comparing Ace2-/y mice on 
normal vs. Trp+ diet or vehicle vs. NAM treated Ace2-/y mice. ## P<0.01 comparing 
Ace2+/y vs. Ace2-/y mice (paired-t-test).  
 
Figure 3. Tryptophan controls antimicrobial peptides and mTOR activity.  
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a,b, Relative mRNA expression levels of antimicrobial peptides in epithelial cells 
isolated from the small intestine of a, unchallenged Ace2+/y and Ace2-/y littermates, and 
b, Ace2+/y mice fed a tryptophan free diet (Trp-) or normal chow (Control). c, Relative 
Defa1 mRNA expression in Ace2+/y and Ace2-/y littermates fed a di-peptidic tryptophan 
diet (Trp+) or normal chow (Control) for 10 days. d,e, Immunohistochemistry to detect 
levels of phosphorylated S6 (brown) in the small intestine of d, unchallenged Ace2+/y 
and Ace2-/y littermates or e, Ace2-/y mice fed a Trp+ or normal chow diet (Control). Scale 
bars, 200μm. f, Colon histopathology (H&E, day 8; scale bars, 100μm) of DSS treated 
wild type mice receiving vehicle or RAPA i.p., initiated 6 days before DSS challenge. 
Values are mean ± SEM of 5-6 mice per group. *P<0.05, **P<0.01 comparing Ace2+/y 
vs. Ace2-/y mice; #P<0.05, ##P<0.01 comparing Ace2+/y mice on normal vs. tryptophan 
free diet or control vs. Trp+ diet in Ace2+/y or Ace2-/y mice (paired-t-test).   
 
Figure 4. Altered gut bacteria from Ace2 mutant mice can confer susceptibility to 
colitis.  
a, Principal coordinate analysis and b, Principal coordinate analysis based on 
unweighted Unifrac analysis showing similarity among ileocaecal bacterial 
communities in Ace2+/y and Ace2-/y mice fed a di-peptidic tryptophan diet (Trp+) or 
normal chow (Control) for 10 days. Distances were calculated by Bray-Curtis algorithm 
from OTU (97% similarity) abundance. Only the two axis with high R2 values are 
shown (axis 1, R2= 0.335; axis 2, R2 squared = 0.8116). Each dot represents data from 
an individual animal. c, Comparison of microbial communities in Ace2+/y and Ace2-/y 
mice fed a Trp+ diet or normal chow (Control). The heat map depicts abundance of the 
top 25 species level OTUs contributing significantly to the axis shown in the weighted 
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PcoA plot. d, Diarrhea scores and e, colon histopathology (H&E, day 7; scale bars, 
100μm) of DSS challenged germfree mice that received intestinal microbiota from 
Ace2+/y or Ace2-/y littermates. Values are mean ± SEM of 4-6 mice per group. *P<0.05 
(paired-t-test).  
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Methods 
Mice. Ace2 ref.4, Agtr1a ref.31, Apelin ref.32, Apj-/- ref.33, and Collectrin ref.19 mutant mice 
have been described previously. All mutant strains were backcrossed onto a C57BL/6 
background more than 6 generations. Apj-/- mice were on a mixed C57BL/6 x CBA 
background. In all experiments, only sex-, age-, and background-matched mice were 
used as controls. Mice were handled and all experiments performed in accordance with 
institutional guidelines. 
Colitis models. Acute colitis in C57BL/6 background mice was induced with 1,5% 
(w/v) DSS (molecular mass 36-50 kDa; MP Biologicals) dissolved in drinking water ad 
libitum for the experimental days 1-7 followed by normal drinking water until the end 
of the experiment. For mixed C57BL/6 x CBA background mice, colitis was induced by 
feeding mice 5% (w/v) DSS. The DSS solutions were made fresh every day. TNBS 
colitis was induced by intrarectal administration of 0.1 ml trinitrobenzene sulphonic 
acid (TNBS; 5 mg/mouse in 40% ethanol), through a feeding needle (Fine Science 
Tools) 3.5 cm proximal to the anal verge as described previously34. Body weight, 
diarrhea, and occult blood (Hemoccult) were determined daily. Diarrhea scores were: 0 
= no diarrhea; 1 = mild diarrhea; 2 = severe watery diarrhea; 3 = mild diarrhea with 
blood; 4 = severe watery diarrhea with blood. Colon length was determined at the end 
of the experiments. Crypt scores, inflammation scores, and disease activity indexes were 
determined as previously described13. For protein-free diet experiment, normal chow 
(20,8% protein) and protein-free (<0,2% protein) diets were obtained from Ssniff 
GmbH, Germany. Mice were fed the protein-free, isocaloric diet for 3 days before start 
of the 1% (w/v) DSS treatment. Due to the severe diarrhea in PFD fed mice, the 
experiment had to be stopped for ethical reasons on day 4. For nicotinamide (NAM) 
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treatment, mice were given NAM (Sigma) in their drinking water (0,4 g/l) from 3 days 
before the first DSS treatment until the end of the experiment. For rapamycin (RAPA) 
treatment, rapamycin (2 mg/kg/d; LC laboratories) or vehicle were administered 
intraperitoneally (i.p.) daily for 6 days with or without NAM treatment. The solvent for 
rapamycin was 0,2% sodium carboxymethylcellulose, 0,25% polysorbate-80 in water. 
For tryptophan rescue experiments, standard food was supplemented with 
glycyl-L-tryptophan (Gly-Trp) hydrate (G0144, TCI Europe) (10mg per gramme of dry 
food) daily for 10 days followed by 1,5% (w/v) DSS treatment. Tryptophan free diet 
was purchased from Oriental Yeast (Tokyo, Japan) and was fed for 18 days before DSS 
challenge. For antibiotic treatment, 4-week-old mice were placed on broad spectrum 
antibiotics ampicillin (1 g/l) and neomycin (0,5 g/l) in drinking water for 4 weeks 
followed by 1,5% (w/v) DSS treatment. For microbiota transplantation, cecal and ileum 
extracts were pooled from Ace2 mutant mice and ACE2 expressing littermates, 
suspended in 3ml PBS, and administered (0,1 ml per mouse) immediately to 
sterile-packed 4-week-old Swiss-Webster germ free mice (Taconic). Transplanted mice 
were maintained in sterile cages for 2 weeks followed by 5% (w/v) DSS treatment. For 
ACE2 reconstitution, mice received intraperitoneal injections of recombinant mouse 
ACE2 protein (0,1 mg/kg) (R&D) daily during 1,5% (w/v) DSS treatment.  
Serum amino acid analyses. Heparinised serum was mixed with an equal part of a 
solution containing 20µg mL-1 each of norleucine (internal standard for Ala, Gly and 
Val), norvaline (for Leu, Ile and Pro) and parachloro-phenylalanine (for all other amino 
acids) and deproteinised by ultrafiltration through a 10 kDa cutoff regenerated cellulose 
ultrafiltration membrane (Millipore). Amino acids were then purified by cation 
exchange, converted to their chloroformate derivatives and separated and quantified by 
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GC/MS in the selected ion monitoring (SIM) mode as previously described8.  
Tryptophan ELISA kit (LDN, BA E-2700) was used to assess Trp serum levels upon 
Gly-Trp treatment. 
Purification of intestinal epithelial cells and mucosal cells. Preparation of small 
intestinal epithelial cells was performed as described3. Briefly, after washing with PBS, 
segments of small intestines were placed in 1,5mM EDTA in Hank’s balanced salt 
solution (HBSS) without calcium and magnesium and tumbled for 10 min at 37oC. The 
mucosa was incubated again with HBSS/EDTA for 10 min at 37oC. The supernatant 
containing the crypts was collected. The number and viability of the crypt epithelial 
cells were determined by 0,1% trypan blue exclusion. Purity of the epithelial cell 
preparation was checked by H&E staining. For mucosa preparations jejunum, ileum, or 
colon were inverted and mucosa was scraped off with a scalpel. 
Quantitative RT-PCR. Total RNA was prepared from isolated small intestinal epithelial 
cells using the RNeasy Mini Kit (Qiagen) in accordance with the manufacturer’s 
instructions. Total RNA (0,2μg) was subjected to reverse transcription using random 
hexamers (Roche) and SuperscriptII (Invitrogen) followed by quantitative PCR analysis. 
The following primers were used:  
GAPDH, 5′ -TCATCAACGGGAAGCCCATCAC-3′ (forward) and 
5′-AGACTCCACGACATACTCAGCACCG-3′ (reverse); 
β-actin, 5′ -GGCTGTATTCCCCTCCATCG-3′  (forward) and 
5′-CCAGTTGGTAACAATGCCATGT-3′ (reverse); 
Defa1, 5′ -TCCTCCTCTCTGCCCTYGTCCTG-3′ (forward) and 
5′-CTCTTCTCCTGGCTGCTCCTC-3′ (reverse); 
Defa3, 5′ -GCTAGGGAGCACTTGTTTGC-3′ (forward) and 
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5′-TTGTTTGAGGAAAGGAGGCA-3′ (reverse); 
Defa4, 5′ -CCAGGGGAAGATGACCAGGCTG-3′ (forward) and 
5′-TGCAGCGACGATTTCTACAAAGGC-3′ (reverse); 
Defa5, 5′ -AGGCTGATCCTATCCACAAAACAG-3′ (forward) and 
5′-TGAAGAGCAGACCCTTCTTGGC-3′ (reverse); 
Defa-rs1, 5′ -CACCACCCAAGCTCCAAATACACAG-3′ (forward) and 
5′-ATCGTGAGGACCAAAAGCAAATGG-3′ (reverse); 
MMP7, 5′ -ACCCTGTTCTGCTTTGTGTGTC-3′ (forward) and 
5′-TCTGAGCCTGTTCCCACTGATG-3′ (reverse); 
Angiogenin1 (ANG1), 5′ -CCATGACGCCAAGCCAAAGG-3′ (forward) and 
5′-GCTTCCATTCGCTCCACAGATG-3′ (reverse); 
Angiogenin4 (ANG4), 5′ -GCTGGGTCTGGTTGTGATTCC-3′ (forward) and 
5′-AGGCGAGGTTAGCTTTCTTTCC-3′ (reverse); 
FABP2, 5′ -AGCTCGGTGTAAACTTTCCCTAC-3′ (forward) and 
5′-AAACCTCTCGGACAGCAATCAG-3′ (reverse); 
Lyz1, 5′ -GCCAAGGTCTACAATCGTTGTGAGTTG-3′ (forward) and 
5′-CAGTCAGCCAGCTTGACACCACG-3′ (reverse); 
Lyz2, 5′ -GGCTGGCTACTATGGAGTCAGCCTG-3′ (forward) and 
5′-GCATTCACAGCTCTTGGGGTTTTG-3′ (reverse); 
Pla2g2e, 5′ -AGGATTCCCCCAAGGATGCCAC-3′ (forward) and 
5′-CAGCCGTTTCTGACAGGAGTTCTGG -3′ (reverse); 
Ace, 5′ -TCATCATCCAGTTCCAGTTCCA-3′ (forward) and 
5′-CGGTGACGAGCCATTCTGT-3′ (reverse); 
Ace2, 5′ -TGGTCTTCTGCCATCCGATT-3′ (forward) and 
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5′-CCATCCACCTCCACTTCTCTAA-3′ (reverse); 
B0AT1, 5′ -AACGCTCATGTATAGCATCTGG-3′ (forward) and 
5′-CAGCCACAGTGACCACAAC-3′ (reverse); 
TLR1, 5′ -AAGAACTCAGGCGAGCAGAG-3′ (forward) and 
5′-TCTGGTAAGGTTTGCGTTTGG-3′ (reverse); 
TLR2, 5′ -CACTTCCAGGTCTTCAGTCTTC-3′ (forward) and 
5′-ACTATGATTGCGGACACATCTC-3′ (reverse); 
TLR3, 5′ -TTGCGTTGCGAAGTGAAGAA-3′ (forward) and 
5′-AGACAGATACCTCAGGCTTGG-3′ (reverse); 
TLR4, 5′ -CAGAACTTCAGTGGCTGGATT-3′ (forward) and 
5′-TGTACTAGGTTCGTCAGATTGG-3′ (reverse); 
TLR5, 5′ -GAGTGAGGTCAGTCCTGGAG-3′ (forward) and 
5′-GAGATGAGGCGTCTGGAGAG-3′ (reverse); 
TLR6, 5′ -TACCGTCAGTGCTGGAAATAGA-3′ (forward) and 
5′-TTCTGTCTTGGCTCATGTTGC-3′ (reverse); 
TLR7, 5′-AGAACCACTCTATGCCTTCAAG-3′ (forward) and 
5′-GTCTCTTCCGTGTCCACATC-3′ (reverse); 
TLR8, 5′ -CCTTCCTTTGTCTATAGAACATGGA-3′ (forward) and 
5′-CACAAGGATAGCTTCTGGAATAGT-3′ (reverse); 
TLR9, 5′ -AGAATCCTCCATCTCCCAACAT-3′ (forward) and 
5′-CAGACTTCAGGAACAGCCAAT-3′ (reverse); 
Western blotting and ELISA. Western blotting was performed with standard protocols 
using isolated primary small intestinal epithelial cells. Primary antibodies reactive to 
phosphorylated S6 (2215; Cell Signaling), S6 (2217; Cell Signaling), and β-actin 
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(Sigma) were used. Blots were washed three times in TBST for 30min, incubated with 
horseradish peroxidase-conjugated secondary antibodies (1:5000 dilution; Jackson 
ImmunoResearch) for 20min, washed three times in TBST, and visualised with 
enhanced chemiluminescence. Small intestine was collected for ELISA assays to detect 
phosphorylated p70S6K or total p70S6K (DYC896, DYC8962; R&D) and colon was 
collected to determine angiotensin II levels (EK-002-12; Phoenix). To analyse 
membrane proteins, total membranes were prepared using mannitol buffer (200mM 
Mannitol, 80mM HEPES, 41mM KOH, pH 7.5 in the presence of protease inhibitor 
cocktail, Sigma). After homogenisation of the samples using MagNA Lyser green beads 
(Roche), total membranes were attained by dual consecutive centrifugation steps (100g 
and 100’000g) at 4°C. 50 µg of total membrane were used per lane for Western blotting. 
The following primary antibodies were used: anti-Ace2 and anti-Ace (R&D Systems, 
1:1000), anti-B0AT1 (Pineda, Berlin,Germany, 1:1000), anti-mouse β-actin (Sigma, St 
Louis, MO, 1:10000). Antibody binding was detected with Immobilon Western 
Chemiluminescent HRP or AP substrates (Millipore, Billerica, MA) and 
chemiluminescence visualised with a DIANA III camera (Raytest, Dietikon, 
Switzerland). 
Histology and immunohistochemistry. For histological analysis, 2-4μm thick sections 
were stained with haematoxylin and eosin (H&E). Immunohistochemistry was 
performed using the automated Ventana system. Sections were incubated with 
antibodies against phosphorylated S6 (Cell Signaling), Ace2 (R&D), Ki67 (Novacastra), 
and cleaved Caspase 3 (Cell Signaling). For phosphorylated S6 and cleaved Caspase 3 
staining, a multimer based detection system (UltraMap) was used. In addition, 
immunofluorescence was performed on cryosections of the kidney and small intestine 
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using anti-Ace2 antibodies at 1:100, anti-B0AT1 at 1:200, and anti-Collectrin at 1:1000 
followed by Alexa488-conjugated anti-goat IgG or Alexa594-labelled anti-rabbit IgG.  
DNA extraction, pyrosequencing, sequence analysis  
Genomic DNA from terminal ileum was extracted by MO BIO PowerSoil DNA 
Isolation kit with modifications:  solution C1 and 20µl of Proteinase K were added to 
feces and incubated for 2 hrs at 50°C to enhance the lysis. Extracted DNA was 
quantified by using the Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen). Variable 
region V1-V2 of the 16S rRNA gene was amplified using the forward primer 
5´-CTATGCGCCTTGCCAGCCCGCTCAGTCAGAGTTTGATCCTGGCTCAG-3´. 
Sequence in Bold face is 454 Life Sciences primer B, the underlined sequence 
represents the broadly conserved bacterial primer 27F. A two-base linker sequence 
(‘TC’) and a four base key (red) were added. The reverse primer (5´- 
CGTATCGCCTCCCTCGCGCCATCAGXXXXXXXXXXCATGCTGCCTCCCGT
AGGAGT-3´) contained the 454 Life Sciences primer A sequence (bold) a unique 10 
base multiplex identifier (MIDs designated as XXXXXXXXXX) to tag each PCR 
product, the broad-range bacterial primer 338R, and a ‘CA’ linker sequence inserted 
between the MIDs and the rRNA gene primer. In addition, a four base key (red) was 
added before the MIDs as described earlier35. Replicate PCR reactions were performed 
for each sample and the respective negative controls. Each reaction consisted of 1 μl (10 
pmol/μl) of each primer, 40 ng of DNA, 1 μl of dNTPs mix (10mM stock), 1.0 units of 
Phusion Hot Start II High-Fidelity DNA Polymerase, and 10 μl of 5x Phusion HF buffer. 
The final volume of reaction was adjusted to 50 μl. Amplification was performed using 
an initial denaturation of 3 min at 98oC followed by 30 cycles, denaturation at 98oC for 
10 seconds, annealing at 55oC for 30 seconds and elongation at 72oC for 30 seconds. 
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Final extension was at 72oC for 10 minutes. Amplified products were run on an agarose 
gel, specific bands excised and amplicons purified using the Qiagen gel purification kit 
(Qiagen, Hilden, Germany). Concentrations of the eluted and purified amplicons were 
measured using the Quant-iT PicoGreen dsDNA Assay Kit (Invitrogen). Equal amounts 
of PCR products were mixed in a single tube and sequenced using Roche 454 titanium 
chemistry. To generate negative control templates for the PCR reaction, water was taken 
as a sample during DNA extraction; in all cases, the PCR reactions from these templates 
were negative.  
Sequence analysis: After pyrosequencing, all sequence reads were screened and filtered 
for quality and length using PANGEAref.36. Sequences were trimmed and binned by 
samples using the specific MIDs as barcode. Sequences not meeting the following 
quality criteria were excluded from further analysis: no perfect match with MID 
sequences or specific primers; reads shorter than 200 bases; mean quality score ≥ 25; 
the presence of any ambiguous base; and/or more than 8 homopolymers. Remaining 
Sequences were aligned using curated SILVA seed database (bacterial reference 
alignment) as a template with Needleman-Wunsch algorithm37. Sequences not matching 
with defined core regions and putative chimeric sequences were detected by using the 
uchime38 command implemented in Mothur39 and were subsequently removed. 
Sequences were further confirmed to originate from bacteria using the Ribosomal Data 
base project (RDP) classifier with 60% bootstrap threshold40. For all the downstream 
analysis, 1000 sequences per samples were randomly sampled to normalize the number 
of reads distribution. In order to reduce the overestimation of distances between 
sequences, leading and trailing periods from aligned files were removed. Pair wise 
distances between sequences were calculated, gaps of any length were treated as single 
 29 
event or mismatch. Sequences with ≥ 97 similarity were clustered using average 
neighbour algorithm in to species level operational taxonomical units (OTUs)41. 
Phylogenetic affiliation of each OTU was performed by using RDP taxonomy and 
template file. To visualize the microbial composition and structure in related on host 
genotype or treatment, distance matrices between samples were generated based on 
weighted (Bray-Curtis similarity) and non-weighted (unweighted UniFrac) algorithms 
and visualised using principal coordinate analysis (PCoA). OTUs contributing for the 
shifting of the samples along the two axes were ascertained by calculating the Spearman 
correlation of each OTU with the two axes in the PCoAref.39. Similarity percentage 
analysis (SIMPER)42 was performed to determine the driving OTUs imparting 
significant differences among bacterial community composition among genotype and 
diet groups. The analysis was performed on Bray Curtis similarity coefficient with the 
program PAST (Paleontological Statistics, ver. 2.14)43. 
Bone marrow transplantation. Eight week old Ace2 mutant and Ace2 wild type mice 
were lethally irradiated with 980 cGy (Gammacell 40). Bone marrow cells were 
harvested from 8-9 week old donor Ace2 mutant or Ace2 wild type mice by flushing the 
femurs and tibias with DMEM. Recipient mice received 5×106 bone marrow cells in 
250µl DMEM from male donor mice by tail vein injection 6 hrs after irradiation. Six 
weeks after transplantation, the genotypes of haematopoietic cells were determined by 
PCR using peripheral blood. The PCR primer set for the mutant Ace2 allele was as 
follows: 5’-CCAGCTCATTCCTCCCACTC-3’ and 
5’-CCGGCTGCTCTTTGAGAGGACA-3’. The PCR primer set for wild-type Ace2 
was: 5’-CTTCATTGGCTCCGTTTCTTAGC-3’ and 
5’-CCGGCTGCTCTTTGAGAGGACA-3’. 
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Calorimetry cages. Average food intake was measured using indirect calorimetry cages 
from TSE Systems over a period of seven days following 48 hrs of acclimatisation. Data 
were analysed with proprietary Phenomaster Analysis Software (TSE Systems) and 
Microsoft Excel. 
Statistical analyses. All data are shown as mean ± SEM. Measurements at single time 
points were analyzed by ANOVA and if significant, further analyzed by a two-tailed 
t-test. P < 0,05 was considered to indicate statistical significance. 
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